These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 22186140)
1. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Huang G; Nishimoto K; Zhou Z; Hughes D; Kleinerman ES Cancer Res; 2012 Feb; 72(4):908-16. PubMed ID: 22186140 [TBL] [Abstract][Full Text] [Related]
2. miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating Yang Y; Huang G; Zhou Z; Fewell JG; Kleinerman ES Mol Cancer Ther; 2018 Jan; 17(1):130-139. PubMed ID: 29079708 [TBL] [Abstract][Full Text] [Related]
3. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases. Koshkina N; Yang Y; Kleinerman ES Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242 [TBL] [Abstract][Full Text] [Related]
4. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases. Huang G; Nishimoto K; Yang Y; Kleinerman ES Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176 [TBL] [Abstract][Full Text] [Related]
5. VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells. Jia SF; Guan H; Duan X; Kleinerman ES J Exp Ther Oncol; 2008; 7(2):89-97. PubMed ID: 18771083 [TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases. Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027 [TBL] [Abstract][Full Text] [Related]
7. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells. Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647 [TBL] [Abstract][Full Text] [Related]
8. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine. Gordon N; Kleinerman ES J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149 [TBL] [Abstract][Full Text] [Related]
9. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases. Gordon N; Kleinerman ES Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411 [TBL] [Abstract][Full Text] [Related]
10. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma. Hirahata M; Osaki M; Kanda Y; Sugimoto Y; Yoshioka Y; Kosaka N; Takeshita F; Fujiwara T; Kawai A; Ito H; Ochiya T; Okada F Cancer Med; 2016 May; 5(5):892-902. PubMed ID: 26817521 [TBL] [Abstract][Full Text] [Related]
11. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma. Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400 [TBL] [Abstract][Full Text] [Related]
12. Fas expression in metastatic osteosarcoma cells is not regulated by CpG island methylation. Huang G; Koshkina NV; Kleinerman ES Oncol Res; 2009; 18(1):31-9. PubMed ID: 19911702 [TBL] [Abstract][Full Text] [Related]
13. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine. Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1. Han K; Chen X; Bian N; Ma B; Yang T; Cai C; Fan Q; Zhou Y; Zhao TB Oncotarget; 2015 Apr; 6(11):8875-89. PubMed ID: 25823925 [TBL] [Abstract][Full Text] [Related]
15. Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells. Duan X; Jia SF; Zhou Z; Langley RR; Bolontrade MF; Kleinerman ES Clin Exp Metastasis; 2004; 21(8):747-53. PubMed ID: 16035619 [TBL] [Abstract][Full Text] [Related]
18. The Role of FAS Receptor Methylation in Osteosarcoma Metastasis. Sun JM; Chow WY; Xu G; Hicks MJ; Nakka M; Shen J; Ng PKS; Taylor AM; Yu A; Farrar JE; Barkauskas DA; Gorlick R; Guidry Auvil JM; Gerhard D; Meltzer P; Guerra R; Man TK; Lau CC; On Behalf Of The Target Osteosarcoma Consortium Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569529 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of pro-angiogenic molecules and events does not relate with an angiogenic switch in metastatic osteosarcoma cells but to cell survival features. Gutiérrez LM; Valenzuela Alvarez M; Yang Y; Spinelli F; Cantero MJ; Alaniz L; García MG; Kleinerman ES; Correa A; Bolontrade MF Apoptosis; 2021 Aug; 26(7-8):447-459. PubMed ID: 34024019 [TBL] [Abstract][Full Text] [Related]
20. MiR-511 mimic transfection inhibits the proliferation, invasion of osteosarcoma cells and reduces metastatic osteosarcoma tumor burden in nude mice via targeting MAPK1. Wu J; Zhang C; Chen L Cancer Biomark; 2019; 26(3):343-351. PubMed ID: 31524148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]